Advanced Health Intelligence Ltd
AHI was delisted on the 31st of January, 2024.
3 hedge funds and large institutions have $7.71K invested in Advanced Health Intelligence Ltd in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
41% more capital invested
Capital invested by funds: $5.47K → $7.71K (+$2.24K)
50% less funds holding
Funds holding: 6 → 3 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$2.73K |
| 2 |
Morgan Stanley
New York
|
+$839 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$728 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$305 |
AHI Hedge Fund Activity: Q4 2023 in Review
3 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Advanced Health Intelligence Ltd (AHI) for Q4 2023, worth a combined $7.71K — up 41% from $5.47K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AHI and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was RhumbLine Advisers, adding an estimated $2.73K. The largest seller was Fifth Third Bancorp, exiting entirely with an estimated $728 sold.
- 3 institutional investors held Advanced Health Intelligence Ltd (AHI) as of Q4 2023, down from 6 in Q3 2023.
- Funds reported $7.71K of Advanced Health Intelligence Ltd stock for Q4 2023, up 41% quarter-over-quarter.
- 0 funds opened new Advanced Health Intelligence Ltd positions in Q4 2023 and 3 closed out, a net change of -3 holders.
- The largest Advanced Health Intelligence Ltd buyer in Q4 2023 was RhumbLine Advisers, an estimated $2.73K added.
- The largest Advanced Health Intelligence Ltd seller in Q4 2023 was Fifth Third Bancorp, an estimated $728 sold.
Based on aggregated 13F filings for Q4 2023.